secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2025-03-14T23:59:59+00:00
Accession:  0001493152-25-010269
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix UroShield study shows 86% fewer UTIs, 70% fewer blockages, cost savings
--------------------------------------------------------------------------------

- 86% reduction in UTI incidence and 70% fewer catheter blockages in independent study published in Australian and New Zealand Continence Journal.
- 82.8% less bladder irrigations and 52.3% fewer catheter changes reported with UroShield use.
- Resource costs reduced by 63.5% over 5 months, easing nursing workload and lowering healthcare expenses.
- CEO Brian Murphy highlighted improved patient comfort and reduced catheter-related interventions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225010269/0001493152-25-010269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225010269/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-010269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer